"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
Descriptor ID |
D011379
|
MeSH Number(s) |
E01.789
|
Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 89 | 89 |
1995 | 0 | 91 | 91 |
1996 | 0 | 94 | 94 |
1997 | 0 | 88 | 88 |
1998 | 0 | 113 | 113 |
1999 | 0 | 140 | 140 |
2000 | 0 | 152 | 152 |
2001 | 0 | 138 | 138 |
2002 | 0 | 165 | 165 |
2003 | 0 | 214 | 214 |
2004 | 0 | 255 | 255 |
2005 | 0 | 262 | 262 |
2006 | 2 | 260 | 262 |
2007 | 0 | 311 | 311 |
2008 | 1 | 290 | 291 |
2009 | 1 | 334 | 335 |
2010 | 0 | 355 | 355 |
2011 | 0 | 459 | 459 |
2012 | 1 | 397 | 398 |
2013 | 3 | 463 | 466 |
2014 | 4 | 482 | 486 |
2015 | 4 | 501 | 505 |
2016 | 9 | 460 | 469 |
2017 | 13 | 492 | 505 |
2018 | 6 | 505 | 511 |
2019 | 4 | 565 | 569 |
2020 | 3 | 491 | 494 |
2021 | 4 | 356 | 360 |
2022 | 1 | 195 | 196 |
2023 | 0 | 200 | 200 |
2024 | 0 | 274 | 274 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response. JCO Precis Oncol. 2024 Dec; 8:e2400288.
-
Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas. Neuro Oncol. 2024 Dec 05; 26(12):2239-2255.
-
The use of cloud based machine learning to predict outcome in intracerebral haemorrhage without explicit programming expertise. Neurosurg Rev. 2024 Dec 03; 47(1):883.
-
Genome-Derived Ampullary Adenocarcinoma Classifier and Postresection Prognostication. JAMA Surg. 2024 Dec 01; 159(12):1365-1373.
-
Myosteatosis Is Associated With Frailty and Poor Physical Function in Patients Undergoing Liver Transplant Evaluation: A Cohort Study. Clin Transplant. 2024 Dec; 38(12):e70034.
-
Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine. Blood. 2024 Nov 21; 144(21):2211-2222.
-
Clinicopathologic features of primary central nervous system anaplastic large cell lymphoma: a multicenter study identifies age and ALK status as prognostic factors. J Hematop. 2024 Dec; 17(4):215-222.
-
Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis. J Hematol Oncol. 2024 Nov 15; 17(1):112.
-
Management of acute chest pain in the Emergency Department: benefits of coronary computed tomography angiography. Int J Cardiovasc Imaging. 2024 Dec; 40(12):2447-2457.
-
Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas. J Immunother Cancer. 2024 Nov 12; 12(11).